Mclean Hospital

Paula Bolton Related Content


Increased Volume and New Services Spur Change in McLean’s Psychiatric Neurotherapeutics Program

On any given day at McLean’s Psychiatric Neurotherapeutics Program, some 50 patients come through the door for ECT (electroconvulsive therapy), 20 or more for TMS (transcranial magnetic stimulation), and about four for the program’s new ketamine infusion service. “That’s a lot of people,” said Teresa Henderson, RN, “and our program had to make some changes to make sure we could handle that volume...

How We Talk About ECT: Replacing Misconceptions with Stories of Success

Unfortunately, because of the way it has been portrayed in books, films, and other media, many people have a mistaken impression of electroconvulsive therapy (ECT). Once known as “electroshock therapy,” ECT has frequently been represented as barbaric and violent, a process that produces memory loss or leads to mind control. Many people remember the dramatic depiction of the therapy in the 1975...

Fighting Depression: TMS and ECT are Sought-After Treatments

Elizabeth See struggled with depression for more than a decade when, in November 2014, she was diagnosed with Goodpasture syndrome, a rare autoimmune disease that attacks the kidneys and lungs. A tennis professional, she suddenly found her livelihood and passion restricted by physical constraints and regular dialysis treatments. TMS and ECT are increasingly sought-after treatments for depression...

Successfully Treating Depression and Other Mental Illnesses Through Non-Pharmacologic Technologies at McLean Hospital

Electroconvulsive therapy (ECT)—a highly effective intervention for chronic depression, mania, and schizophrenia—and transcranial magnetic stimulation (TMS)—used for severe depression—are increasingly becoming viable options for successfully treating patients, especially those who may not respond well to medication. “Patients are increasingly looking for alternative solutions when medications...